投稿注册咨询:400-008-5413 销售咨询:010-6029 9110、80259978
Irshad H Chaudry:Estrogens for the treatment of trauma and severe hemorrhage PPT讲座视频 2017中华医学会急诊医学分会第二十次全国急诊医学学术年会
标题: Estrogens for the treatment of trauma and severe hemorrhage
讲者: Irshad H Chaudry
单位: 美国阿拉巴马大学
关键词:
播放: 2581
论文摘要:

Trauma is the leading cause of death in persons between the ages of 1 and 44. The preponderance of trauma victims are young males; their mortality rate after trauma is not only higher compared to females but they are also more susceptible to subsequent sepsis. Our studies show that after the induction of sepsis in animals, even if the animals had undergone soft-tissue trauma-hemorrhage (T-H) and resuscitation first, the survival rate in proestrus (PE) females was significantly higher than in age-matched males. Ovariectomized (OVX) females, however, were extremely susceptible to sepsis after T-H as compared to PE females. Our clinical epidemiological studies also show the premenopausal females tolerate trauma better than age matched males. Thus, the prevailing hormonal milieu at the time of injury dictates whether the host is going to be susceptible to sepsis and mortality or tolerant to sepsis and mortality after trauma.

Administration of 17β-estradiol (E2) after major blood loss (60% of the circulating blood volume), maintained the rats in a state of permissive hypotension for 6 hr with no additional fluid administration. Survival in the E2-treated animals was significantly higher than in vehicle-treated animals. To examine if ethinyl estradiol-3-SO4 (EE-3-SO4) was also protective, rats were given a single dose of 1 mg/kg EE-3-SO4 in 0.4 ml/kg of saline following controlled 60% hemorrhage. The survival rates in EE-3-SO4-treated rats increased 6-fold even in the absence of resuscitation. Administration of a single dose of 1 mg/kg EE-3-SO4 in 1 ml/kg of saline following severe hemorrhage also increased survival in 60% acutely-bled minipigs by 3.5-fold

In a lateral fluid percussion injury model of traumatic brain injury (TBI), E2 administration one hr. after TBI, markedly decreased edema formation and ICP at 24 hr after TBI. Brain metabolism (using fludoexoyglucose-PET/CT and diffusion tension imaging analysis) indicated that the relative % standard uptake values in E2-treated rats were significantly higher than in the vehicle-treated animals. To examine if EE-3-SO4 was also protective following TBI, rats were given EE-3-SO4 or vehicle 1 hr post-TBI. Animal activity was reduced after TBI more so that the EEs treated animals. The weight loss 3 days post-TBI was significantly less in the EE-treated group than in the vehicle-treated group.

This hormone (i.e., estrogens) should therefore be considered as a novel adjunct for preserving life when fluid resuscitation is not possible for an extended period of time after major blood loss. Furthermore, EE-3-SO4 promotes recovery by increasing brain metabolism, resolving edema and improving physiologic parameters if administered 1 hr post-TBI. EE-3-SO4 administration post-TBI improves physical activity, and decreases weight loss in animals. Estrogen therefore appears to be neuroprotective even after TBI. These results, together with similar findings in post-hemorrhage minipigs, support the use of EE-3-SO4 for: 1) severe hemorrhage when standard resuscitation is not available or feasible, and 2) conditions in which prolonged transportation periods are required for definitive treatment of the injured. Thus, evaluation of the safety/efficacy of EE-3-SO4 in humans encountering severe trauma is desirable.

该讲者其他视频
相关视频
该讲者其他论文
相关论文

l 腹腔感染诊疗新进展

作者: 李维勤

单位: 中国人民解放军东部战区总医院

来源: 2017中华医学会急诊医学分会第二十次全国急诊医学学术年会

l 急诊CAP诊疗策略

作者: 王军宇

单位: 首都医科大学附属北京朝阳医院

来源: 2017中华医学会急诊医学分会第二十次全国急诊医学学术年会

l -

作者: 高燕

单位: 中国人民解放军北部战区总医院

来源: 2017中华医学会急诊医学分会第二十次全国急诊医学学术年会

l -

作者: 王仲

单位: 北京清华长庚医院

来源: 2017中华医学会急诊医学分会第二十次全国急诊医学学术年会

学术交流区 (0条留言)
最新留言
产品&服务
• 学会/协会管理系统
• 会务通学术会议服务平台
• 现场注册签到管理系统
• 会场幻灯传输转播系统
• 学术会议网络直播系统
• E-Poster电子壁报系统
• 企业数字助展服务
• 花生会议管理系统
帮助中心
• 功能更新
• 常见问题
关于我们
• 公司简介
• 版权声明
• 联系我们
微信扫描
美迪康官方微信
Copyright©2007-2017 MEDCON. All Rights Reserved.北京美迪康信息咨询有限公司 版权所有. 京ICP备11011505号-31 京公网安备 11011502002826号